MDT

98.76

+2.13%↑

A

145.85

-1.34%↓

VEEV

219.49

-1.71%↓

HQY

87.3

+1.61%↑

NEOG

9.53

+3.36%↑

MDT

98.76

+2.13%↑

A

145.85

-1.34%↓

VEEV

219.49

-1.71%↓

HQY

87.3

+1.61%↑

NEOG

9.53

+3.36%↑

MDT

98.76

+2.13%↑

A

145.85

-1.34%↓

VEEV

219.49

-1.71%↓

HQY

87.3

+1.61%↑

NEOG

9.53

+3.36%↑

MDT

98.76

+2.13%↑

A

145.85

-1.34%↓

VEEV

219.49

-1.71%↓

HQY

87.3

+1.61%↑

NEOG

9.53

+3.36%↑

MDT

98.76

+2.13%↑

A

145.85

-1.34%↓

VEEV

219.49

-1.71%↓

HQY

87.3

+1.61%↑

NEOG

9.53

+3.36%↑

Search

ResMed Inc

Deschisă

SectorSănătate

258.54 0.72

Rezumat

Modificarea prețului

24h

Curent

Minim

256.49

Maxim

259.96

Indicatori cheie

By Trading Economics

Venit

-31M

349M

Vânzări

-12M

1.3B

P/E

Medie Sector

26.391

90.831

Randament dividend

0.87

Marjă de profit

26.096

Angajați

10,600

EBITDA

-29M

503M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+15.44% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.87%

2.20%

Următoarele câștiguri

29 ian. 2026

Data viitoare de dividende

19 mar. 2026

Următoarea dată ex-dividende

12 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-193M

38B

Deschiderea anterioară

257.82

Închiderea anterioară

258.54

Sentimentul știrilor

By Acuity

33%

67%

68 / 361 Clasament în Healthcare

ResMed Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 ian. 2026, 22:41 UTC

Achiziții, Fuziuni, Preluări

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 ian. 2026, 00:00 UTC

Câștiguri

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 ian. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 ian. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 ian. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 ian. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 ian. 2026, 22:56 UTC

Achiziții, Fuziuni, Preluări

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 ian. 2026, 22:53 UTC

Achiziții, Fuziuni, Preluări

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 ian. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 ian. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 ian. 2026, 22:09 UTC

Câștiguri

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 ian. 2026, 22:08 UTC

Câștiguri

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 ian. 2026, 22:08 UTC

Câștiguri

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 ian. 2026, 21:53 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 ian. 2026, 21:53 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 ian. 2026, 21:52 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Announces Positive Profit Alert for 2025

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Citigroup Acting as Financial Advisor to WuXi XDC

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 ian. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 ian. 2026, 21:50 UTC

Market Talk
Câștiguri

Financial Services Roundup: Market Talk

14 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 ian. 2026, 21:49 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 ian. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 ian. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

WuXi XDC Makes Cash Offer for BioDlink International

14 ian. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 ian. 2026, 20:30 UTC

Market Talk
Câștiguri

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 ian. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 ian. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 ian. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 ian. 2026, 19:06 UTC

Market Talk
Câștiguri

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Comparație

Modificare preț

ResMed Inc Așteptări

Obiectiv de preț

By TipRanks

15.44% sus

Prognoză pe 12 luni

Medie 294 USD  15.44%

Maxim 345 USD

Minim 260 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruResMed Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

6

Cumpărare

5

Păstrare

0

Vânzare

Sentiment

By Acuity

68 / 361 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat